Canata, Eric G.
HRN: 26-38-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/15/2024
12/22/2024
IV
300mg
Q8 X7days
Multiple Physical Injuries Sec To MVA
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft TissueEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes